A drug-target network-based approach to evaluate the efficacy of medicinal plants for type II diabetes mellitus

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Gu, Jiangyong ^a   Chen, Lirong ^a   Yuan, Gu ^a   Xu, Xiaojie ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMYLASE PANCREAS ISOENZYME; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; CATHEPSIN D; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; ESTROGEN RELATED RECEPTOR ALPHA; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOCORTICOID RECEPTOR; GLUCOKINASE; HERBACEOUS AGENT; HEXOKINASE 1; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULINASE; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATURAL PRODUCT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN SERINE THREONINE KINASE; PYRUVATE KINASE; SOMATOMEDIN C RECEPTOR; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANTIDIABETIC ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; BINDING AFFINITY; BIOLOGICAL ACTIVITY; BLACK PEPPER; BUPLEURUM CHINENSE; CALENDULA OFFICINALIS; CELASTRUS; CRATAEGUS PINNATIFIDA; DATURA METEL; DRUG EFFICACY; DRUG TARGETING; FICUS; GANODERMA LUCIDUM; GARCINIA; GLUCOSE BLOOD LEVEL; GRAPE; HERBAL MEDICINE; HOLARRHENA; HUMAN; HYDROGEN BOND; HYPERICUM PERFORATUM; LANTANA CAMARA; MANGO; MEDICINAL PLANT; MELIA; MELIA AZEDARACH; MOLECULAR DOCKING; MOMORDICA CHARANTIA; MURRAYA; NON INSULIN DEPENDENT DIABETES MELLITUS; PACHYSANDRA; PICRORHIZA KURROA; PINELLIA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN TARGETING; SOLANUM DULCAMARA; SWEET ORANGE; TRIPTERYGIUM WILFORDII;

EID: 84886690282     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/203614     Document Type: Article

References (62)

1. Lin Y., Sun Z., Current views on type 2 diabetes. Journal of Endocrinology 2010 204 1 1 11 2-s2.0-73949146152 10.1677/JOE-09-0260
2. Stumvoll M., Goldstein B. J., van Haeften T. W., Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 2005 365 9467 1333 1346 2-s2.0-17044386953 10.1016/S0140-6736(05)61032-X
3. Gu J., Zhang H., Chen L., Xu S., Yuan G., Xu X., Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus. Computational Biology and Chemistry 2011 35 5 293 297 2-s2.0-80052088034 10.1016/j.compbiolchem.2011.07.003
4. Sengupta U., Ukil S., Dimitrova N., Agrawal S., Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications. PLoS ONE 2009 4 12 2-s2.0-77949508610 10.1371/journal.pone.0008100 e8100
5. Smith S. C. Jr., Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine 2007 120 3 S3 S11 2-s2.0-33847063390 10.1016/j.amjmed.2007.01.002 (Pubitemid 46274577)
6. Mazzone T., Chait A., Plutzky J., Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. The Lancet 2008 371 9626 1800 1809 2-s2.0-43849095463 10.1016/S0140-6736(08)60768-0 (Pubitemid 351697956)
7. Tian S., Li Y., Li D., Modeling compound-target interaction network of traditional chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design. Journal of Chemical Information and Modeling 2013 53 7 1787 1803
8. Zhang T. T., Jiang J. G., Active ingredients of traditional chinese medicine in the treatment of diabetes and diabetic complications. Expert Opinion on Investigational Drugs 2012 21 11 1625 1642
9. Zhao H.-L., Tong P. C. Y., Chan J. C. N., Traditional Chinese medicine in the treatment of diabetes. Nutritional Management of Diabetes Mellitus and Dysmetabolic Syndrome 2006 11 15 29 2-s2.0-33750111898
10. Li J., Lu C., Jiang M., Traditional chinese medicine-based network pharmacology could lead to new multicompound drug discovery. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 10.1155/2012/149762 149762
11. Li S., Zhang B., Zhang N., Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biology 2011 1 1, article S10 2-s2.0-79959199033 10.1186/1752-0509-5-S1-S10
12. Ma T., Tan C., Zhang H., Wang M., Ding W., Li S., Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Molecular BioSystems 2010 6 4 613 619 2-s2.0-77949682260 10.1039/b914024g
13. Li S., Network systems underlying traditional Chinese medicine syndrome and herb formula. Current Bioinformatics 2009 4 3 188 196 2-s2.0-70549112019 10.2174/157489309789071129
14. Wu X., Jiang R., Zhang M. Q., Li S., Network-based global inference of human disease genes. Molecular Systems Biology 2008 4, article 189 2-s2.0-43249114206 10.1038/msb.2008.27 (Pubitemid 351655223)
15. Tian S., Li Y. Y., Wang J. M., Drug-likeness analysis of traditional chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional chinese medicines. Journal of Cheminformatics 2013 5 1 10.1186/1758-2946-5-5
16. Shen M. Y., Tian S., Li Y. Y., Drug-likeness analysis of traditional chinese medicines: 1. Property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional chinese medicines. Journal of Cheminformatics 2012 4 1, article 31 10.1186/1758-2946-4- 31
17. Tian S., Wang J. M., Li Y. Y., Drug-likeness analysis of traditional chinese medicines: 3. Prediction of drug-likeness using machine learning approaches. Molecular Pharmaceutics 2012 9 10 2875 2886
18. Hopkins A. L., Network pharmacology. Nature Biotechnology 2007 25 10 1110 1111 2-s2.0-35148824614 10.1038/nbt1007-1110 (Pubitemid 47538107)
19. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 11 682 690 2-s2.0-54249155522 10.1038/nchembio.118
20. Li S., Zhang B., Traditional chinese medicine network pharmacology: theory, methodology and application. Chinese Journal of Natural Medicines 2013 11 2 110 120
21. Tao W. Y., Xu X., Wang X., Network pharmacology-based prediction of the active ingredients and potential targets of chinese herbal radix curcumae formula for application to cardiovascular disease. Journal of Ethnopharmacology 2013 145 1 1 10
22. Zhao S., Li S., Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE 2010 5 7 2-s2.0-77955628292 10.1371/journal.pone.0011764 e11764
23. Gu J., Chen Y., Li S., Li Y., Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis. BMC Systems Biology 2010 4, article 47 2-s2.0-77951076168 10.1186/1752-0509-4-47
24. Pei L. X., Bao Y. W., Liu S., Material basis of chinese herbal formulas explored by combining pharmacokinetics with network pharmacology. Plos ONE 2013 8 2
25. Zhang A., Sun H., Yang B., Wang X., Predicting new molecular targets for rhein using network pharmacology. BMC Systems Biology 2012 6, article 20 2-s2.0-84858605520 10.1186/1752-0509-6-20
26. Zhao J., Jiang P., Zhang W., Molecular networks for the study of TCM pharmacology. Briefings in Bioinformatics 2009 11 4 417 430 2-s2.0-77955039434 10.1093/bib/bbp063
27. Yan H., Zhang B., Li S., Zhao Q., A formal model for analyzing drug combination effects and its application in TNF- α -induced NF B pathway. BMC Systems Biology 2010 4, article 50 2-s2.0-77951134093 10.1186/1752-0509-4-50
28. Li S., Zhang B., Jiang D., Wei Y., Zhang N., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010 11 11, article S6 2-s2.0-78650832745 10.1186/1471-2105-11-S11-S6
29. Yildirim M. A., Goh K.-I., Cusick M. E., Barabási A.-L., Vidal M., Drug-target network. Nature Biotechnology 2007 25 10 1119 1126 2-s2.0-35148838537 10.1038/nbt1338 (Pubitemid 47538114)
30. Janga S. C., Tzakos A., Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Molecular BioSystems 2009 5 12 1536 1548 2-s2.0-72949101438 10.1039/b908147j
31. Mestres J., Gregori-Puigjané E., Valverde S., Solé R. V., The topology of drug-target interaction networks: implicit dependence on drug properties and target families. Molecular BioSystems 2009 5 9 1051 1057 2-s2.0-68949119585 10.1039/b905821b
32. Vogt I., Mestres J., Drug-target networks. Molecular Informatics 2010 29 1-2 10 14 2-s2.0-77952627289 10.1002/minf.200900069
33. Kanehisa M., Goto S., Sato Y., Kegg for integration and interpretation of large-scale molecular data sets. Nucleic Acids Research 2012 40 1 D109 D114
34. Knox C., Law V., Jewison T., Liu P., Ly S., Frolkis A., Pon A., Banco K., Mak C., Neveu V., Djoumbou Y., Eisner R., Guo A. C., Wishart D. S., DrugBank 3.0: a comprehensive resource for "Omics" research on drugs. Nucleic Acids Research 2011 39 1 D1035 D1041 2-s2.0-78651287426 10.1093/nar/gkq1126
35. Arokiyaraj S., Balamurugan R., Augustian P., Antihyperglycemic effect of Hypericum perforatum ethyl acetate extract on streptozotocin-induced diabetic rats. Asian Pacific Journal of Tropical Biomedicine 2011 1 5 386 390 2-s2.0-79959471205 10.1016/S2221-1691(11)60085-3
36. Hasanein P., Shahidi S., Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats. Phytotherapy Research 2011 25 4 544 549 2-s2.0-79953223746 10.1002/ptr.3298
37. You Y.-H., Lin Z.-B., Protective effects of Ganoderma lucidum polysaccharides peptide on injury of macrophages induced by reactive oxygen species. Acta Pharmacologica Sinica 2002 23 9 787 791 2-s2.0-0036712254 (Pubitemid 35012979)
38. Ali K. M., Chatterjee K., De D., Efficacy of aqueous extract of seed of holarrhena antidysenterica for the management of diabetes in experimental model rat: a correlative study with antihyperlipidemic activity. International Journal of Applied Research in Natural Products 2009 2 3 13 21
39. Mana S., Singhal S., Sharma N., Singh D., Hypoglycemic effect of Holarrhena antidysenterica seeds on streptozotocin induced diabetic rats. International Journal of PharmTech Research 2010 2 2 1325 1329 2-s2.0-77954729861
40. Samudram P., Vasuki R., Rajeshwari H., Geetha A., Sathiya Moorthi P., Antioxidant and antihepatotoxic activities of ethanolic crude extract of Melia azedarach and Piper longum. Journal of Medicinal Plant Research 2009 3 12 1078 1083 2-s2.0-75649102128
41. Krishna Murthy B., Nammi S., Kota M. K., Krishna Rao R. V., Koteswara Rao N., Annapurna A., Evaluation of hypoglycemic and antihyperglycemic effects of Datura metel (Linn.) seeds in normal and alloxan-induced diabetic rats. Journal of Ethnopharmacology 2004 91 1 95 98 2-s2.0-1442351150 10.1016/j.jep.2003.12.010 (Pubitemid 38270234)
42. Murch S. J., Alan A. R., Cao J., Saxena P. K., Melatonin and serotonin in flowers and fruits of Datura metel L. Journal of Pineal Research 2009 47 3 277 283 2-s2.0-69949140809 10.1111/j.1600-079X.2009.00711.x
43. Asok Kumar K., Uma Maheswari M., Sivashanmugam A. T., Subhadra Devi V., Prasanth N. V., Ravi T. K., Hypoglycemic effect of Ficus microcarpa leaves (Chinese Banyan) on alloxan-induced diabetic rats. Journal of Biological Sciences 2007 7 2 321 326 2-s2.0-34250884535 (Pubitemid 46971055)
44. Ge Y., Xie H., Li S., Treatment of diabetic nephropathy with tripterygium wilfordii hook f extract: a prospective, randomized, controlled clinical trial. Journal of Translational Medicine 2013 11, article 134
45. Chakraborthy G. S., Arora R., Majee C., Antidiabetic and antihyperlipidaemic effect of hydro-alcoholic extract of calendula officinalis. International Research Journal of Pharmacy 2011 2 1 61 65
46. Orhan N., Aslan M., Orhan D. D., Ergun F., Yeşilada E., In-vivo assessment of antidiabetic and antioxidant activities of grapevine leaves (Vitis vinifera) in diabetic rats. Journal of Ethnopharmacology 2006 108 2 280 286 2-s2.0-33750312811 10.1016/j.jep.2006.05.010 (Pubitemid 44635033)
47. Aderibigbe A. O., Emudianughe T. S., Lawal B. A. S., Evaluation of the antidiabetic action of Mangifera indica in mice. Phytotherapy Research 2001 15 5 456 458 2-s2.0-0034893114 10.1002/ptr.859 (Pubitemid 32762401)
48. Kaleem M., Sheema S., Sarmad H., Bano B., Protective effects of Piper nigrum and Vinca rosea in alloxan induced diabetic rats. Indian Journal of Physiology and Pharmacology 2005 49 1 65 71 2-s2.0-14044274981 (Pubitemid 40278887)
49. Asano N., Nash R. J., Molyneux R. J., Fleet G. W. J., Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron Asymmetry 2000 11 8 1645 1680 2-s2.0-0034607947 10.1016/S0957-4166(00)00113-0 (Pubitemid 30320886)
50. Ooi C. P., Yassin Z., Hamid T.-A., Momordica charantia for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2010 2 10.1002/14651858.CD007845.pub3 2-s2.0-77950919479
51. Leung L., Birtwhistle R., Kotecha J., Hannah S., Cuthbertson S., Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. British Journal of Nutrition 2009 102 12 1703 1708 2-s2.0-74949111350 10.1017/S0007114509992054
52. Kazmi I., Rahman M., Afzal M., Gupta G., Saleem S., Afzal O., Shaharyar M. A., Nautiyal U., Ahmed S., Anwar F., Anti-diabetic potential of ursolic acid stearoyl glucoside: a new triterpenic gycosidic ester from Lantana camara. Fitoterapia 2012 83 1 142 146 2-s2.0-83055184172 10.1016/j.fitote.2011.10.004
53. Tiwari P., Tamrakar A. K., Ahmad R., Srivastava M. N., Kumar R., Lakshmi V., Srivastava A. K., Antihyperglycaemic activity of Ceriops tagal in normoglycaemic and streptozotocin-induced diabetic rats. Medicinal Chemistry Research 2008 17 2-7 74 84 2-s2.0-52949089037 10.1007/s00044-007-9038-3
54. Gu J. Y., Gui Y. S., Chen L. R., Use of natural products as chemical library for drug discovery and network pharmacology. Plos ONE 2013 8 4 e62839
55. Qiao X., Hou T., Zhang W., Guo S., Xu X., A 3D structure database of components from Chinese traditional medicinal herbs. Journal of Chemical Information and Computer Sciences 2002 42 3 481 489 2-s2.0-0036557840 10.1021/ci010113h (Pubitemid 35355253)
56. Jiang X., Kumar K., Hu X., Wallqvist A., Reifman J., DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chemistry Central Journal 2008 2 1, article 18 2-s2.0-52249109585 10.1186/1752-153X-2-18
57. Morris G. M., Ruth H., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J., Software news and updates AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Journal of Computational Chemistry 2009 30 16 2785 2791 2-s2.0-70349932423 10.1002/jcc.21256
58. Gu J. Y., Li Q., Chen L. R., Platelet aggregation pathway network-based approach for evaluating compounds efficacy. Evidence-Based Complementary and Alternative Medicine 2013 2013 8 10.1155/2013/425707 425707
59. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 1997 23 1-3 3 25 2-s2.0-0031024171 10.1016/S0169-409X(96)00423-1 (Pubitemid 27046991)
60. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J., Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 2001 46 1-3 3 26 2-s2.0-0035289779 10.1016/S0169-409X(00)00129-0 (Pubitemid 33653411)
61. Vuorela P., Leinonen M., Saikku P., Tammela P., Rauha J.-P., Wennberg T., Vuorela H., Natural products in the process of finding new drug candidates. Current Medicinal Chemistry 2004 11 11 1375 1389 2-s2.0-2942566175 (Pubitemid 38735784)
62. McChesney J. D., Venkataraman S. K., Henri J. T., Plant natural products: back to the future or into extinction? Phytochemistry 2007 68 14 2015 2022 2-s2.0-34447096207 10.1016/j.phytochem.2007.04.032 (Pubitemid 47030619)